Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Consensus Rating of “Buy” from Analysts

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) has received an average recommendation of “Buy” from the eight analysts that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold rating, two have issued a buy rating and three have issued a strong buy rating on the company.

A number of brokerages have weighed in on RBGLY. Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th. Barclays cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Tuesday, February 4th. HSBC upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Finally, Royal Bank of Canada restated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th.

Reckitt Benckiser Group Stock Down 0.4 %

RBGLY opened at $13.45 on Monday. Reckitt Benckiser Group has a 12-month low of $10.24 and a 12-month high of $14.10. The firm’s fifty day moving average price is $13.12 and its 200 day moving average price is $12.54. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97.

Reckitt Benckiser Group Increases Dividend

The business also recently announced a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be given a $0.2909 dividend. The ex-dividend date of this dividend is Friday, April 11th. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.19.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.